Fundraising Fox

Annette Clancy

Investor

Pharma M&A Strategy at Jeito Capital

France

Find your path to Annette

144 people in our graph share verified history with Annette — schools, employers, funds. One of them is your warm intro.

Erin MooreunlockedAnnette: together at GlaxoSmithKline (2005–2008)
×8Annette: together at GlaxoSmithKline
×2Annette: together at Sobi - Swedish Orphan Biovitrum AB (publ)
Annette: together at Jeito Capital

About

Jeito founding team member working on Pharma M&A strategy, with over 30 years of international pharma experience at GSK, where she led worldwide transactions and alliance management.

Experience

  1. Quell TherapeuticsMember Board of Directorscurrent2025 — present
  2. JEITOOperational Investorcurrent2020 — present
  3. Sobi - Swedish Orphan Biovitrum AB (publ)Chairperson of the Board2024
  4. Swedish Orphan Biovitrum AB (Sobi)Non Executive Director2014 — 2024
  5. ENYO PharmaChair Board of Directors2016 — 2023Lyon Area, France
  6. Obseva LtdChair of the Board and NED2013 — 2023
  7. Frazier Healthcare VenturesSenior Advisor2009 — 2017
  8. Genable Technologies LimitedChairman of the Board2013 — 2016
  9. GlaxoSmithKlineGlaxoSmith Kline1978 — 2008

Skills & more

Biotechnology8Mergers1Business Strategy9Life Sciences5Business Development5Contract Negotiation1Global Marketing1Cross-functional Team Leadership3Mergers & Acquisitions5Venture Capital2Drug Development2Licensing1
+5 moreStart-upsBiopharmaceuticalsTechnology TransferPharmaceutical IndustryStrategy

From Annette's professional profile.

Colleagues at Jeito Capital

Frequently asked questions

Who is Annette Clancy?
Jeito founding team member working on Pharma M&A strategy, with over 30 years of international pharma experience at GSK, where she led worldwide transactions and alliance management.
Where does Annette Clancy work?
Annette Clancy is Pharma M&A Strategy at Jeito Capital.

Shared employers